Prediction of postprandial glycemic exposure: Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength

Diabetes Care

Volumn 29, Issue 12, 2006, Pages 2708-2713

  Cohen, Ohad ^a   Basu, Rita ^a   Bock, Gerlies ^a   Dalla Man, Chiara ^b   Campioni, Marco ^b   Basu, Ananda ^a   Toffolo, Gianna ^b   Cobelli, Claudio ^b   Rizza, Robert A ^a,c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CARBOHYDRATE DIET; CONTROLLED STUDY; DEMOGRAPHY; DIET RESTRICTION; FEMALE; FITNESS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; MUSCLE STRENGTH; POSTPRANDIAL STATE;

ADULT; AGED; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; FASTING; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; PHYSICAL FITNESS; POSTPRANDIAL PERIOD; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 33845498666     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1118     Document Type: Article

References (42)

1. Sorkin JD, Muller DC, Fleg JL, Andres R: The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28:2626-2632, 2005
2. Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ: Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 42:1050-1054, 1999
3. de Vegt F, Dekker JM, Ruhé HG, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ: Hyperglycaemia is associated with allcause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926 -931, 1999
4. Schianca GPC, Rossi A, Sainaghi PO, Maduli E, Bartoli E: The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care 26:1333-1337, 2003
5. Stern MP, Fatehi P, Williams K, Haffner SM: Predicting future cardiovascualr disease: do we need the oral glucose tolerance test? Diabetes Care 25:1851-1856, 2002
6. Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Yano K, Curb JD: Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care 22:1262-1265, 1999
7. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diabnostic criteria. Arch Intern Med 161:397-404, 2001
8. Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL: Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 24:1397-1402, 2001
9. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PWF: Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25:1845-1850, 2002
10. Balkau B, Forhan A, Eschwège E: Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study. Diabetologia 45:1224-1230, 2002
11. Nakagami T, the DECODA Study Group: Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 47:385-394, 2004
12. Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Gatti CD, Joch H, Volpe M, Lüscher TF: High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: a role of protein kinase C and reactive oxygen species. Circulation 107:1017-1023, 2003
13. Ceriello A, Taboga C, Tonutti L, Quagliaro L, Piconi L, Bais B, Da Ros B, Motz E: Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 106:1211-1218, 2002
14. Lee SH, Woo HG, Baik E-J, Moon CH: High glucose enhances IL-1β-induced cyclooxygenase-2 expression in rat vascular smooth muscle cells. Life Sci 68:57- 67, 2000
15. Liu W, Schoenkerman A, Lowe WLJ: Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am J Physiol Endocrinol Metab 279:E782-E790, 2000
16. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-1348, 2001
17. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939-1945, 2000
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3167, 2003
19. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413-420, 2004
20. Brownlee M, Hirsch IB: Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 295:1-2, 2006
21. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136:575-581, 2002
22. Saaristo T, Peltonen M, Lindstrom J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J: Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2:67-72, 2005
23. Basu R, Dalla Man C, Campioni M, Basu A, Klee G, Toffolo G, Cobelli C, Rizza RA: Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action and hepatic insulin. Diabetes 55:2001-2014, 2006
24. Jensen MD, Kanaley JA, Reed JE, Sheedy PF: Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr 61:274 -278, 1995
25. Caumo A, Bergman RN, Cobelli C: Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab 85:4396-4402, 2000
26. Dalla Man C, Caumo A, Basu R, Rizza R, Toffolo G, Cobelli C: Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method. Am J Physiol Endocrinol Metab 287:E637-E643, 2004
27. Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C: Oral glucose tolerance test minimal model indexes of β-cell function and insulin sensitivity. Diabetes 50:150 -158, 2001
28. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
29. Diabetes Trial Unit: HOMA Calculator (article online), 2004. Available from http://www.dtu.ox.ac.uk/. Accessed 12 September 2005
30. Barret PHR, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster D: SAAM II: simulation, analysis and modeling software for tracer and pharmacokinetic studies. Metabolism 47:484-492, 1998
31. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793-801, 2002
32. Lakka TA, Laukkanen JA, Rauramaa R, Salonen R, Lakka H-M, Kaplan GA, Salonen JT: Cardiorespiratory fitness and the progression of carotid atherosclerosis in middle-aged men. Ann Intern Med 134:12-20, 2001
33. Arcavi L, Behar S, Caspi A, Reshef N, Boyko V, Knobler H: High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study. Am Heart J 147:239-245, 2004
34. Bjørnholt JV, Erikssen G, Aaser E, Sandvik L, Nitter-Hauge S, Jervell J, Erikssen J, Thaulow E: Fasting blood glucose: an underestimated risk factor for cardiovascular death: results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 22:45- 49, 1999
35. Port SC, Goodarzi MO, Boyle NG, Jennrich RI: Blood glucose: a strong risk factor for mortality in nondiabetic patients with cardiovascular disease. Am Heart J 150:209-214, 2005
36. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, for The STOP-NIDDM Trial Research Group: Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486-494, 2003
37. Manzella D, Grella R, Abbatecola AM, Paolisso G: Repaglinide administration improves brachial reactivity in type 2 diabetic patients. Diabetes Care 28:366-371, 2005
38. Yamasaki Y, Katakami N, Hayaishi-Okano R, Matsuhisa M, Kajimoto Y, Kosugi K, Hatano M, Hori M: α-Glucosidase inhibitor reduces the progression of carotid intima-media thickness. Diabetes Res Clin Prac 67:204 -210, 2005
39. McMahon M, Marsh H, Rizza RA: Comparison of the pattern of postprandial carbohydrate metabolism following ingestion of a liquid glucose drink or a solid mixed meal. J Clin Endocrinol Metab 68:647-653, 1989
40. Basu A, Alzaid A, Dinneen S, Caumo A, Cobelli C, Rizza RA: Effects of a change in the pattern of insulin delivery on carbohydrate tolerance in diabetic and nondiabetic humans in the presence of differing degrees of insulin resistance. J Clin Invest 97:2351-2361, 1996
41. Ghiglione M, Blazquez E, Uttenthal LO, de Diego JG, Alvarez E, George SK, Bloom SR: Glucagon-like peptide-1 does not have a role in hepatic carbohydrate metabolism. Diabetologia 28:920 -921, 1985
42. Basu R, Singh R, Basu A, Johnson CM, Rizza RA: Effect of nutrient ingestion on total-body and splanchnic cortisol production in humans. Diabetes 55:667-674, 2006